Hormonal contraceptive eligibility for women at high risk of HIV

Guidance Statement
World Health Organization, Department of Reproductive Health and Research, 2017

20 pp. 2.5 MB
http://apps.who.int/iris/bitstream/10665/254662/1/WHO-RHR-17.04-eng.pdf?ua=1

The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime risk of acquiring HIV, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls. Through consensus, the Guideline Development Group (GDG) arrived at new recommendations for progestogen-only injectables and that women at high risk of acquiring HIV can use all methods of contraception.

(Visited 22 times, 1 visits today)
This entry was posted in General, HIV - AIDS - STI, Maternal & Child Health, Sexual & Reproductive Health. Bookmark the permalink.